Navigation Links
Solta Medical Reports Fourth Quarter and Full Year 2012 Results
Date:2/19/2013

HAYWARD, Calif., Feb. 19, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced results for the fourth quarter ended December 31, 2012. Revenue for the fourth quarter was $39.8 million, an increase of $6.6 million, or 20%, as compared to the fourth quarter of 2011. Revenue from Liposonix, the Company's non-invasive fat reduction system, was $7.6 million, which was generated from shipments of 90 systems and associated consumables. For the full year 2012, revenue of $144.5 million grew year-over-year by $28.6 million or 25%.

"The fourth quarter provided a strong ending to a productive year for Solta," said Stephen J. Fanning, Chairman, President and CEO of Solta.  "We completed the integration of the Liposonix acquisition ahead of plan and the first year of the Liposonix commercial launch exceeded our expectations. During the year, we shipped approximately 360 Liposonix systems, generating $32 million in revenue. We also generated double digit revenue growth from our Clear + Brilliant brand. We continued to execute well, extending our broad product portfolio through a large distribution network and focusing on recurring revenue.  The increase in the gross margin, and our delivery of positive non-GAAP EBITDA in the fourth quarter and in every quarter over the past three years demonstrate the leverage in our business model. We also generated cash from operations of $1.4 million in the fourth quarter and $4.4 million for the full year ended 2012, and finished the year with $38 million in cash on the balance sheet."

Fourth Quarter Financial HighlightsTotal product revenue from treatment tips and consumables for the quarter was $18.8 million, a year-over-year increase of $2.9 million or 18%, and represented 47% of total revenue.  Revenue from North America and international markets rose y
'/>"/>

SOURCE Solta Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Solta Medical to Report Fourth Quarter 2012 Results Release and Host Conference Call on February 19, 2013
2. Solta Medical to Present at the Leerink Swann Global Healthcare Conference in New York on February 14, 2013
3. Solta Medical to Acquire Sound Surgical Technologies
4. Solta Medical Reports Third Quarter Results
5. Solta Medical And BTL Industries Resolve Patent Dispute
6. Solta Medical to Present at the 32nd Annual Canaccord Growth Conference
7. Solta Medical, Inc. Closes Public Offering of Common Stock
8. Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
9. Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
10. Solta Medical Reports Second Quarter Results
11. Solta Medical to Present at the JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015  A new, cutting ... First Coast that promises to revolutionize the way prostate ... at the world-renowned Montsouris Institute in Paris, ... prostate biopsy in the North Florida ... innovative technology in prostate cancer diagnosis and management to ...
(Date:4/21/2015)... 21, 2015 Whitehall-based ... dazzling export-led growth in just 4 years. ... part in winning the Queen,s Award for Enterprise, ... Oxford PharmaGenesis. As part of the world,s first ... bring new medicines to the world in areas ...
(Date:4/21/2015)... , April 21, 2015 Softheon, ... marketplace integration and business operation, has confirmed its ... the Centers of Medicare & Medicaid Services (CMS). ... channel with access to the Federal Data Hub ... consumers into qualified health insurance plans. ...
Breaking Medicine Technology:Kasraeian Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection Technology 2Kasraeian Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection Technology 3Queen's Award Crowns Achievements of Fast-growing London Consultancy 2Queen's Award Crowns Achievements of Fast-growing London Consultancy 3Queen's Award Crowns Achievements of Fast-growing London Consultancy 4Queen's Award Crowns Achievements of Fast-growing London Consultancy 5Softheon Confirms Web Broker Entity (WBE) Status with the Centers of Medicare & Medicaid Services (CMS) 2
... Feb. 9, 2011 GeoVax Labs, Inc. (OTC Bulletin ... develops and tests innovative HIV/AIDS vaccines, announced today the ... Alabama Vaccine Research Clinic (AVRC) of the University of ... therapeutic vaccine trial. Although the GeoVax vaccines are currently ...
... The Covaris® LE220™ high performance ultra-sonicator has received ... at the LabAutomation 2011 conference in Palm Springs ... laboratory automation conference and exhibition, bringing science, technology, and ... LabAutomation are evaluated by a team of industry experts. ...
Cached Medicine Technology:GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine 2GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine 3Covaris Receives the Society for Laboratory Automation and Screening (SLAS) New Product Award at LabAutomation 2011 2
(Date:4/21/2015)... Louis, Missouri (PRWEB) April 22, 2015 ... Virginia are making headway, comments the St. Louis law ... court hearing the 7 transvaginal mesh multidistrict litigations (MDLs) ... concerns all of the transvaginal mesh MDLs except Neomedic. ... status conference schedule. Legal representatives for plaintiffs and defendants ...
(Date:4/21/2015)... Plainsboro, N.J. (PRWEB) April 22, 2015 ... the mission of improving healthcare delivery for the benefit ... palliative care fits into the value equation of ACOs ... publication of The American Journal of Managed Care ... and Diane E. Meier, MD, are both at the ...
(Date:4/21/2015)... 22, 2015 “An incredible number of ... aware of many products that are detrimental,” said author ... the dangers of physical inactivity and the many dangerous ... that exist. Furthermore, smokers in general don’t ... his own success in losing weight along with the ...
(Date:4/21/2015)... FL (PRWEB) April 22, 2015 Debt ... the nation’s efforts to raise awareness on financial literacy ... . DMCC is helping to promote the importance of ... , For over a decade, DMCC has committed to ... DMCC University incorporates their free educational materials to help ...
(Date:4/21/2015)... NY (PRWEB) April 22, 2015 ... National Services Inc. as a 2015-2016 inductee into the ... recognized with this prestigious distinction for leadership in business. ... Local Chapters, NAPW is the nation's leading networking organization ... Leslie into this exceptional group of professional women,” said ...
Breaking Medicine News(10 mins):Health News:Carey Danis & Lowe Comments on West Virginia Transvaginal Mesh Lawsuits 2Health News:Carey Danis & Lowe Comments on West Virginia Transvaginal Mesh Lawsuits 3Health News:Palliative Care and ACOs: A Perfect Fit 2Health News:New Book shares ‘A Doctor’s Prescription for Longevity and Survival’ 2Health News:New Book shares ‘A Doctor’s Prescription for Longevity and Survival’ 3Health News:DMCC Releases Financial Education Website to Support Financial Literacy Month 2Health News:National Association of Professional Women Announces Leslie Bender, ARS’s Vice President of Risk Management and General Counsel, a 2015 Professional Woman of the Year 2
... of two proteins in mammalian embryos prevents the development ... at the Medical College of Wisconsin, Milwaukee, has found. ... issue of Developmental Biology, was led by Stephen Duncan, ... the Medical College. , This is the first study ...
... second monoclonal antibody drug to chemotherapy looks promising for ... Clinic researchers working with the North Central Cancer Treatment ... analysis were released May 15 as part of the ... Oncology. , Researchers found that 95 percent of ...
... Shandong, China, May 16 /Xinhua-PRNewswire-FirstCall/ --,Shengtai Pharmaceutical, Inc. ... a leading manufacturer and distributor,of high-quality, pharmaceutical grade ... the three months ended March 31, 2008., ... -- Sales increased 64.8% to $20.7 million ...
... Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today that ... presentation at two,upcoming investor conferences., Mr. Myers will ... in London at 9:30 a.m. BST (4:30 a.m. EDT) ... 2008 Mr. Myers will present at the FBR Capital,Markets ...
... China Yingxia,International, Inc. (OTC Bulletin Board: CYXI) ("China ... nutraceutical industry engaged in the,development, manufacture and distribution ... products in the People,s Republic,of China ("PRC"), today ... March 31, 2008., First Quarter 2008 ...
... anti-inflammatory medication also known by the trade name Celebrex, ... proliferation measurement of precancerous lesions in the lung, according ... D. Anderson Cancer Center. This finding demonstrates the significance ... at higher risk of developing the disease. , The ...
Cached Medicine News:Health News:Medical College of Wisconsin researchers identify proteins that help develop mammalian hearts 2Health News:Adding epratuzumab to standard therapy 2Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 2Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 3Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 4Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 5Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 6Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 7Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 8Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 9Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 10Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 11Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 12Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 2Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 3Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 4Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 5Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 6Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 7Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 8Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 9Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 3
The cemented hip joint prosthesis system....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
The MS-30 is a highly polished cemented stem....
Easy-to-use system for displaced femoral neck fractures in the low demand patient....
Medicine Products: